Last updated on May 2020

Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Stage I Colon Cancer AJCC v8 | Stage IIIA Rectal Cancer AJCC v8 | Stage IIC Rectal Cancer AJCC v8 | Stage III Colon Cancer AJCC v8 | Stage IIIB Rectal Cancer AJCC v8 | Stage I Rectal Cancer AJCC v8 | Stage IIC Colon Cancer AJCC v8 | Stage III Rectal Cancer AJCC v8 | Stage IIIB Colon Cancer AJCC v8 | Stage IIA Rectal Cancer AJCC v8 | Stage IIIA Colon Cancer AJCC v8 | Stage II Rectal Cancer AJCC v8 | Stage IIA Colon Cancer AJCC v8 | Stage IIB Rectal Cancer AJCC v8 | Stage II Colon Cancer AJCC v8 | Stage IIIC Colon Cancer AJCC v8 | Stage IIIC Rectal Cancer AJCC v8 | Stage IIB Colon Cancer AJCC v8
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Patients must have a life expectancy of >= 24 months
  • Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-3
  • Patients must have a newly diagnosed colon or rectal cancer (initial diagnosis, either a biopsy or curative surgery, whichever is most recent) within 60 days of registration and have not yet received radiation or chemotherapy
  • Patients must have stage I, II, or III disease at the time of enrollment and will be treated with curative-intent; this can be defined either clinically or pathologically if they have already undergone surgery; for staging of both colon and rectal cancer, the definition of stage I-III is based on the seventh edition (2010) or an updated version of the tumor, node, metastasis (TNM) staging system
  • Patients are not eligible if they are already enrolled on a treatment clinical trial at the time of registration; they can remain on the study if they subsequently enroll on a treatment clinical trial during the study time period
  • Patients who choose to not receive radiation and/or chemotherapy after a curative-intent surgery are eligible to participate
  • Patients with a history of previous malignancy (except non-melanoma skin or cervical in-situ cancer) treated (with either surgery, chemotherapy, and/or radiation) within the last 3 years are not eligible
  • Patients must be able to complete questionnaires in English
  • Patients must sign and give written informed consent in accordance with institutional and federal guidelines

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.